Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Testing wearable devices to help manage stroke risk factors

Tests smart wearable devices in people at high risk of stroke.

Key facts

Who runs it
Affiliated Hospital of Nantong University
Where
Nantong, ChinaSee the site
Trial code
Registry title
Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations
Status
Recruiting
People taking part
300 people, planned
Started
20 Apr 2025
Planned end
20 Apr 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Wearable Devices
Record updated
30 April 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults at high risk of stroke, for example people with high blood pressure, diabetes, atrial fibrillation, smoking, little physical activity or overweight. They must be able to use a smart wearable device.

Age
30 years or older
Sex
All sexes can join
Disease stage
Diagnosed with hypertension, diabetes or atrial fibrillation, or being a smoker, physically inactive, or obese or overweight

Main reasons for not taking part

  • Diagnosed with a cancer (malignancy)
  • Diagnosed with a psychiatric disorder
  • Diagnosed with cognitive impairment
  • Unable to operate smart wearable devices

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Diagnosed with hypertension
  • Diagnosed with diabetes
  • Diagnosed with atrial fibrillation
  • Smoking subjects
  • Physical inactive subjects;
  • Obesity and overweight subjects
  • Must be able to use smart wearable devices

Who cannot take part

  • Diagnosed with malignancies
  • Diagnosed with psychiatric disorders
  • Diagnosed with cognitive impairment
  • Unable to operate smart wearable devices

Where in China

  • Affiliated Hospital of Nantong UniversityNantong, ChinaContact: Qiuhong Ji, MD, PhDTaking people

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the control effect of smart wearable devices on key risk factors in the high-risk populations for stroke

The 2 groups in the trial

  • With Wearable DevicesTreatment being tested

    Participants utilize wearable devices (smart wristbands) 24 hours a day for 6 months and receive medication reminders for each use and heart rate monitoring.

    Treatment: Wearable Devices

  • Without Wearable DevicesNo study treatment, for comparison

    Participants do not utilize wearable devices (smart wristbands) .

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations
Plain-language title
Testing wearable devices to help manage stroke risk factorsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
30 April 2025